Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.
Nath K, Shekarkhand T, Nemirovsky D, Derkach A, Costa BA, Nishimura N, Farzana T, Rueda C, Chung DJ, Landau HJ, Lahoud OB, Scordo M, Shah GL, Hassoun H, Maclachlan K, Korde N, Shah UA, Tan CR, Hultcrantz M, Giralt SA, Usmani SZ, Shahid Z, Mailankody S, Lesokhin AM.
Nath K, et al. Among authors: shahid z.
Blood Cancer J. 2024 May 31;14(1):88. doi: 10.1038/s41408-024-01043-5.
Blood Cancer J. 2024.
PMID: 38821925
Free PMC article.